Step 4. Determine What is Feasible

Comorbidities

“I take a water pill for my heart failure.”

Consider

  • ASCVD: GLP 1RA, SGLT2i
  • HF or CKD: SGLT2i (adjust doses of all diabetes agents for renal function)

Avoid

  • ASCVD: thiazolidinediones
  • HF: thiazolidinediones , saxagliptin
  • CKD: thiazolidinediones

Contraindications and Adverse Effects

“I get up to go to the bathroom several times each night.”

Consider

  • ↓ Weight: GLP 1RA, SGLT2i
  • ↓ Volume and blood pressure: SGLT2i

Avoid

  • ↑ Weight: insulin, thiazolidinedione
  • ↑ Diarrhea: metformin
  • ↑ Urination: SGLT2i
  • Pancreatitis: GLP 1RA and DPP 4i
  • Thyroid tumors: GLP 1RA

Cost

“Sometimes I split tablets to save money.”

Consider

  • Low-cost agents (metformin, thiazolidinediones, sulfonylureas, human insulin)

Avoid

  • High-cost agents (GLP 1RA, SGLT2i, DPP 4i, insulin analogs)

Health Equity and Access

“I can’t drive to get healthy foods or to exercise classes.”

Consider

  • Home exercise options, low-cost meal delivery services, low-cost transportation services, involve case manager or social worker

Avoid

  • Recommending diet and exercise options that are not accessible to patient

Functional Status and Support

“My family member helps me take my medicines.”

Consider

  • Cognitive or functional challenges: simple oral regimen, no blood glucose testing
  • Fall risk: low hypoglycemia risk agents
  • Assistance: involve others (ie, visiting nurse, paid caregiver, etc) in medication management

Avoid

  • Regimen that is burdensome to patient and family or does not align with patient goals and support system

Notes:

ASCVD = atherosclerotic cardiovascular disease, HF = heart failure, CKD = chronic kidney disease


Posted

in

by

Tags: